A
Anna Caciotti
Researcher at Boston Children's Hospital
Publications - 41
Citations - 1053
Anna Caciotti is an academic researcher from Boston Children's Hospital. The author has contributed to research in topics: GLB1 & Gangliosidosis. The author has an hindex of 19, co-authored 36 publications receiving 893 citations. Previous affiliations of Anna Caciotti include University of Florence.
Papers
More filters
Journal Article
Activation of cam promoterless gene by ISR10 transposition in an Escherichia coli population under stress conditions
TL;DR: Sequence analysis of plasmid DNA extracted from E. coli Cam r colonies revealed that the insertion of IS10R mobile element, transposed from the bacterial chromosome, occur- red soon upstream of cam gene rendering it transcriptable by the host RNA-polymerase, allowing the surviving of the E.E. coli cells in the presence of the antibiotic.
Journal ArticleDOI
Case Report: Dramatic Cholestasis Responsive to Steroids in a Newborn Homozygous for H63D HFE Variant
Luca Filippi,Sara Tamagnini,Francesca Lorenzoni,Anna Caciotti,Amelia Morrone,Rosa T. Scaramuzzo +5 more
TL;DR: In a newborn with very precocious liver failure, cholestatic jaundice, and low γ-glutamyl transpeptidase, progressive hepatosplenomegaly induced a progressively worsening respiratory distress, that was successfully treated with steroids, it is suggested that hereditary hemochromatosis ought to be included in the panel of the possible causes of neonatalCholestasis.
Journal ArticleDOI
3-Methylglutaconic Aciduria Type I Due to AUH Defect: The Case Report of a Diagnostic Odyssey and a Review of the Literature
Francesca Nardecchia,Anna Caciotti,Teresa Giovanniello,S De Leo,Lorenzo Ferri,Serena Galosi,Silvia Santagata,Barbara Torres,Laura Bernardini,Claudia Carducci,Amelia Morrone,Vincenzo Leuzzi +11 more
TL;DR: The case of a 31-month-old female child referred to the authors' center after the detection of increased 3-hydroxyisovalerylcarnitine levels at newborn screening and the presence of two microdeletions in compound heterozygosity encompassing the AUH gene, which confirmed the diagnosis of MGCA1, exemplifies the importance of the biochemical phenotype in the differential diagnosis of metabolic diseases.
Journal ArticleDOI
Synthesis of a New β-Galactosidase Inhibitor Displaying Pharmacological Chaperone Properties for GM1 Gangliosidosis
Francesca Clemente,Macarena Martínez-Bailén,Camilla Matassini,Amelia Morrone,Silvia Falliano,Anna Caciotti,P Paoli,Andrea Goti,Francesca Cardona +8 more
TL;DR: Five new trihydroxypiperidine iminosugars are synthesized with the aim of identifying new pharmacological chaperones for GM1 gangliosidosis and compound 12 showed chaperoning properties since it enhanced β-Gal activity by 40% when tested on GM1 patients bearing the p.Ile51Asn/p.Arg201His mutations.
Journal ArticleDOI
Fluorescent In Situ Staining and Flow Cytometric Procedures as New Pre-Diagnostic Tests for Sialidosis, GM1 Gangliosidosis and Niemann–Pick Type C
Claudia Capitini,Federica Feo,Anna Caciotti,Rodolfo Tonin,Matteo Lulli,Domenico A. Coviello,Renzo Guerrini,Martino Calamai,Amelia Morrone +8 more
TL;DR: It is demonstrated that with the methods, it is possible to clearly distinguish the levels of accumulated metabolites in fibroblasts from affected and unaffected patients for all the three pathologies considered, and the methods proved to be rapid, sensitive, unbiased, and potentially applicable to other LSDs.